We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Essa Pharma Inc
16 own
46 watching
Current Price
$1.61
$-0.02
(-1.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
139.77M
52-Week High
11.67000
52-Week Low
1.40000
Average Volume
0.04M
Dividend Yield
--
P/E Ratio
--
Market Capitalization139.77M52-Week High11.6700052-Week Low1.40000Average Volume0.04MDividend Yield--P/E Ratio--What does the Essa Pharma Inc do?
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Read More
How much money does Essa Pharma Inc make?
News & Events about Essa Pharma Inc.
CNW Group - News Releases
1 year ago
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer Canada NewsWire SOUTH SAN...
PR Newswire
1 year ago
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer PR Newswire SOUTH SAN...
Ticker Report
1 year ago
ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) Research analysts at Oppenheimer issued their Q1 2024 earnings per share (EPS) estimates for ESSA Pharma in a note issued to investors on Tuesday, February 7th. Oppenheimer analyst M. Breidenbach expects that the company will post ...
PR Newswire
2years ago
Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? PR Newswire NEW YORK, Oct. 28, 2022 NEW YORK, Oct. 28, 2022 /PRNewswire/ -- InvestorsObserverissues...
Zolmax
2years ago
Woodline Partners LP increased its stake in shares of ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, HoldingsChannel reports. The firm owned 684,247 shares of the companys stock after buying an additional 507,239 shares during the quarter. Woodline Partners LPs ...
Frequently Asked Questions
Frequently Asked Questions
What is Essa Pharma Inc share price today?
Can Indians buy Essa Pharma Inc shares?
How can I buy Essa Pharma Inc shares from India?
Can Fractional shares of Essa Pharma Inc be purchased?
What are the documents required to start investing in Essa Pharma Inc stocks?
What is today’s traded volume of Essa Pharma Inc?
What is today’s market capitalisation of Essa Pharma Inc?
What is the 52-Week High and Low Range of Essa Pharma Inc?
What percentage is Essa Pharma Inc down from its 52-Week High?
What percentage is Essa Pharma Inc up from its 52-Week Low?
Current Price
$1.61
$-0.02
(-1.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.